Skip to content

Clinical trials

Hypertension trials in South Korea with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Status: Unknown status Country / region: South Korea Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20112
20133
20142
20152
20162
20173
20183
20197
20203
20213
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical8
Seoul National University Hospital5
HK inno.N Corporation3
IlDong Pharmaceutical Co Ltd3
Yonsei University3
AJU Pharm Co., Ltd.2
Ahn-Gook Pharmaceuticals Co.,Ltd2
Daewoong Pharmaceutical Co. LTD.2
Hanlim Pharm. Co., Ltd.2
Alvogen Korea1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension38
Dyslipidemias7
Essential Hypertension4
Hyperlipidemias3
Prehypertension3
Isolated Systolic Hypertension2
Renal Insufficiency, Chronic2
Albuminuria1
Angina, Stable1
Atherosclerosis1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.